Literature DB >> 34202113

Quantification of Ceftaroline in Human Plasma Using High-Performance Liquid Chromatography with Ultraviolet Detection: Application to Pharmacokinetic Studies.

Ana Alarcia-Lacalle1,2, Helena Barrasa2,3, Javier Maynar2,3, Andrés Canut-Blasco2,4, Carmen Gómez-González2,4, María Ángeles Solinís1,2, Arantxazu Isla1,2, Alicia Rodríguez-Gascón1,2.   

Abstract

This study was conducted to develop a rapid, simple and reproducible method for the quantification of ceftaroline in plasma samples by high-performance liquid chromatography with ultraviolet detection (HPLC-UV). Sample processing consisted of methanol precipitation and then, after centrifugation, the supernatant was injected into the HPLC system, working in isocratic mode. Ceftaroline was detected at 238 nm at a short acquisition time (less than 5 min). The calibration curve was linear over the concentration range from 0.25 to 40 µg/mL, and the method appeared to be selective, precise and accurate. Ceftaroline in plasma samples was stable at -80 °C for at least 3 months. The method was successfully applied to characterize the pharmacokinetic profile of ceftaroline in two critically ill patients and to evaluate whether the pharmacokinetic/pharmacodynamic (PK/PD) target was reached or not with the dose regimen administered.

Entities:  

Keywords:  HPLC; ceftaroline fosamil; pharmacokinetics; pharmacokinetics/pharmacodynamics

Year:  2021        PMID: 34202113     DOI: 10.3390/pharmaceutics13070959

Source DB:  PubMed          Journal:  Pharmaceutics        ISSN: 1999-4923            Impact factor:   6.321


  22 in total

1.  Comparative ceftaroline activity tested against pathogens associated with community-acquired pneumonia: results from an international surveillance study.

Authors:  Ronald N Jones; David J Farrell; Rodrigo E Mendes; Helio S Sader
Journal:  J Antimicrob Chemother       Date:  2011-04       Impact factor: 5.790

Review 2.  On-Site Therapeutic Drug Monitoring.

Authors:  H Ceren Ates; Jason A Roberts; Jeffrey Lipman; Anthony E G Cass; Gerald A Urban; Can Dincer
Journal:  Trends Biotechnol       Date:  2020-04-02       Impact factor: 19.536

Review 3.  Ceftaroline fosamil: a novel broad-spectrum cephalosporin with expanded anti-Gram-positive activity.

Authors:  Donald Biek; Ian A Critchley; Todd A Riccobene; Dirk A Thye
Journal:  J Antimicrob Chemother       Date:  2010-11       Impact factor: 5.790

4.  Co-opting the cell wall in fighting methicillin-resistant Staphylococcus aureus: potent inhibition of PBP 2a by two anti-MRSA beta-lactam antibiotics.

Authors:  Adriel Villegas-Estrada; Mijoon Lee; Dusan Hesek; Sergei B Vakulenko; Shahriar Mobashery
Journal:  J Am Chem Soc       Date:  2008-06-27       Impact factor: 15.419

5.  In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.

Authors:  Yigong Ge; Donald Biek; George H Talbot; Daniel F Sahm
Journal:  Antimicrob Agents Chemother       Date:  2008-07-14       Impact factor: 5.191

6.  Antimicrobial activities of Ceftaroline and ME1036 tested against clinical strains of community-acquired methicillin-resistant Staphylococcus aureus.

Authors:  Helio S Sader; Thomas R Fritsche; Ronald N Jones
Journal:  Antimicrob Agents Chemother       Date:  2008-01-07       Impact factor: 5.191

7.  Optimizing ceftaroline dosing in critically ill patients undergoing continuous renal replacement therapy.

Authors:  Shamir Kalaria; Sarah Williford; Dong Guo; Yan Shu; Christopher Medlin; Matthew Li; Siu Yan Amy Yeung; Farhan Ali; Wisna Jean; Mathangi Gopalakrishnan; Mojdeh Heavner
Journal:  Pharmacotherapy       Date:  2021-02-07       Impact factor: 4.705

Review 8.  A narrative review of predictors for β-lactam antibiotic exposure during empirical treatment in critically ill patients.

Authors:  Alan Abdulla; Tim M J Ewoldt; Ilse M Purmer; Anouk E Muller; Diederik Gommers; Henrik Endeman; Birgit C P Koch
Journal:  Expert Opin Drug Metab Toxicol       Date:  2021-02-02       Impact factor: 4.481

9.  Pharmacokinetic and Pharmacodynamic Target Attainment in Adult and Pediatric Patients Following Administration of Ceftaroline Fosamil as a 5-Minute Infusion.

Authors:  Todd A Riccobene; Timothy J Carrothers; William Knebel; Susan Raber; Phylinda L S Chan
Journal:  Clin Pharmacol Drug Dev       Date:  2021-01-19

10.  Failure of target attainment of beta-lactam antibiotics in critically ill patients and associated risk factors: a two-center prospective study (EXPAT).

Authors:  Alan Abdulla; Annemieke Dijkstra; Nicole G M Hunfeld; Henrik Endeman; Soma Bahmany; Tim M J Ewoldt; Anouk E Muller; Teun van Gelder; Diederik Gommers; Birgit C P Koch
Journal:  Crit Care       Date:  2020-09-15       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.